Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

1.180 +0.020 (+1.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,040,409
Open 1.150
Bid (Size) 1.150 (17)
Ask (Size) 1.180 (158)
Prev. Close 1.160
Today's Range 1.120 - 1.180
52wk Range 0.8511 - 2.720
Shares Outstanding 247,079,374
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds
Genomics company Pacific Biosciences of California (NASDAQ:PACB) announced better-than-expected revenue in Q1 CY2025, but sales fell by 4.3% year on year to $37.15 million. Its non-GAAP loss of $0.15... 
Via StockStory
Topics World Trade
Exposures Tariff
Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at life sciences tools & services stocks,... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
-34.4%
-34.4%
1 Month
+2.6%
+2.6%
3 Month
-1.7%
-1.7%
6 Month
-42.3%
-42.3%
1 Year
-40.4%
-40.4%

More News

Read More
3 Out-of-Favor Stocks Skating on Thin Ice
Via StockStory
Topics Supply Chain
Exposures Supply Chain
Where Pacific Biosciences Stands With Analysts
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
PacBio Stock Soars On Plans To Reduce Spending Over NIH Funding Uncertainty, Tariffs: Retail Is Overjoyed
Via Stocktwits
Where Pacific Biosciences Stands With Analysts
Via Benzinga
Earnings Scheduled For February 13, 2025
Via Benzinga
1 Russell 2000 Stock with Exciting Potential and 2 to Approach with Caution
Via StockStory
PacBio (NASDAQ:PACB) Beats Expectations in Strong Q1
Via StockStory
PacBio (PACB) Q1 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant
Via Benzinga
1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar
Via StockStory
Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know
Via StockStory
Topics Artificial Intelligence Government World Trade
Exposures Artificial Intelligence Political Tariff
Sequencing Company PacBio Cuts Costs Amid Uncertainty Around NIH Funding And New Tariffs
Via Benzinga
Simply Good Foods, Pacific Biosciences of California, Kura Sushi, Delta Air Lines And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Assessing Pacific Biosciences: Insights From 6 Financial Analysts
Via Benzinga
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
Via Benzinga
3 Reasons to Sell PACB and 1 Stock to Buy Instead
Via StockStory
Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Healthcare Stock to Target This Week and 2 to Turn Down
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday
Via Benzinga
PacBio (NASDAQ:PACB) Misses Q4 Sales Targets
Via StockStory

Frequently Asked Questions

Is Pacific Biosciences of California, Inc. - Common Stock publicly traded?
Yes, Pacific Biosciences of California, Inc. - Common Stock is publicly traded.
What exchange does Pacific Biosciences of California, Inc. - Common Stock trade on?
Pacific Biosciences of California, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pacific Biosciences of California, Inc. - Common Stock?
The ticker symbol for Pacific Biosciences of California, Inc. - Common Stock is PACB on the Nasdaq Stock Market
What is the current price of Pacific Biosciences of California, Inc. - Common Stock?
The current price of Pacific Biosciences of California, Inc. - Common Stock is 1.180
When was Pacific Biosciences of California, Inc. - Common Stock last traded?
The last trade of Pacific Biosciences of California, Inc. - Common Stock was at 06/12/25 04:00 PM ET
What is the market capitalization of Pacific Biosciences of California, Inc. - Common Stock?
The market capitalization of Pacific Biosciences of California, Inc. - Common Stock is 291.55M
How many shares of Pacific Biosciences of California, Inc. - Common Stock are outstanding?
Pacific Biosciences of California, Inc. - Common Stock has 292M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.